These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30611789)

  • 1. Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells - The involvement of carbonyl reductase 1 inhibition.
    Piska K; Koczurkiewicz P; Wnuk D; Karnas E; Bucki A; Wójcik-Pszczoła K; Jamrozik M; Michalik M; Kołaczkowski M; Pękala E
    Chem Biol Interact; 2019 Feb; 300():40-48. PubMed ID: 30611789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinnamic acid derivatives as chemosensitising agents against DOX-treated lung cancer cells - Involvement of carbonyl reductase 1.
    Koczurkiewicz-Adamczyk P; Piska K; Gunia-Krzyżak A; Bucki A; Jamrozik M; Lorenc E; Ryszawy D; Wójcik-Pszczoła K; Michalik M; Marona H; Kołaczkowski M; Pękala E
    Eur J Pharm Sci; 2020 Nov; 154():105511. PubMed ID: 32801001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
    Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
    Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in Triple-Negative Breast Cancer.
    Chen D; Ma Y; Li P; Liu M; Fang Y; Zhang J; Zhang B; Hui Y; Yin Y
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31242627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperlongumine increases the apoptotic effect of doxorubicin and paclitaxel in a cervical cancer cell line.
    Seber S; Sirin DY; Yetisyigit T; Bilgen T
    Niger J Clin Pract; 2020 Mar; 23(3):386-391. PubMed ID: 32134040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-Regulation of Carbonyl Reductase 1 Renders Development of Doxorubicin Resistance in Human Gastrointestinal Cancers.
    Matsunaga T; Kezuka C; Morikawa Y; Suzuki A; Endo S; Iguchi K; Miura T; Nishinaka T; Terada T; El-Kabbani O; Hara A; Ikari A
    Biol Pharm Bull; 2015; 38(9):1309-19. PubMed ID: 26328486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled green tea polyphenol-based coordination nanomaterials to improve chemotherapy efficacy by inhibition of carbonyl reductase 1.
    Shan L; Gao G; Wang W; Tang W; Wang Z; Yang Z; Fan W; Zhu G; Zhai K; Jacobson O; Dai Y; Chen X
    Biomaterials; 2019 Jul; 210():62-69. PubMed ID: 31075724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases.
    Hofman J; Skarka A; Havrankova J; Wsol V
    Biochem Pharmacol; 2015 Aug; 96(3):168-78. PubMed ID: 25986883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperlongumine, a piper alkaloid, enhances the efficacy of doxorubicin in breast cancer: involvement of glucose import, ROS, NF-κB and lncRNAs.
    Awasthee N; Shekher A; Rai V; Verma SS; Mishra S; Dhasmana A; Gupta SC
    Apoptosis; 2022 Apr; 27(3-4):261-282. PubMed ID: 35122181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells.
    Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P
    Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phellinus linteus sensitises apoptosis induced by doxorubicin in prostate cancer.
    Collins L; Zhu T; Guo J; Xiao ZJ; Chen CY
    Br J Cancer; 2006 Aug; 95(3):282-8. PubMed ID: 16868541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells.
    Rawat L; Hegde H; Hoti SL; Nayak V
    Biomed Pharmacother; 2020 Aug; 128():110243. PubMed ID: 32470748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperlongumine inhibits head and neck squamous cell carcinoma proliferation by docking to Akt.
    Lv F; Deng M; Bai J; Zou D; Wang J; Li H; Zhang Y; Ji X
    Phytother Res; 2020 Dec; 34(12):3345-3358. PubMed ID: 32798277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperlongumine suppresses bladder cancer invasion via inhibiting epithelial mesenchymal transition and F-actin reorganization.
    Liu D; Qiu XY; Wu X; Hu DX; Li CY; Yu SB; Pan F; Chen XQ
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):165-172. PubMed ID: 29037814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver.
    Kassner N; Huse K; Martin HJ; Gödtel-Armbrust U; Metzger A; Meineke I; Brockmöller J; Klein K; Zanger UM; Maser E; Wojnowski L
    Drug Metab Dispos; 2008 Oct; 36(10):2113-20. PubMed ID: 18635746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
    Han SS; Han S; Kamberos NL
    Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperlongumine induces ROS mediated apoptosis by transcriptional regulation of SMAD4/P21/P53 genes and synergizes with doxorubicin in osteosarcoma cells.
    Rawat L; Nayak V
    Chem Biol Interact; 2022 Feb; 354():109832. PubMed ID: 35085581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells.
    Gavelová M; Hladíková J; Vildová L; Novotná R; Vondrácek J; Krcmár P; Machala M; Skálová L
    Chem Biol Interact; 2008 Oct; 176(1):9-18. PubMed ID: 18755171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells.
    Alsherbiny MA; Bhuyan DJ; Radwan I; Chang D; Li CG
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521-A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics.
    Jamrozik M; Piska K; Bucki A; Koczurkiewicz-Adamczyk P; Sapa M; Władyka B; Pękala E; Kołaczkowski M
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.